Letter from the President & CEO

Printer Friendly

Dear Friends,


Every day, 500 people are diagnosed with a brain tumor. They join more than 700,000 who are currently living with the fear, frustration and uncertainty a brain tumor diagnosis brings.  There are more than 120 different types of brain tumors which means there is no one answer to the brain tumor challenge.

For 40 years, the American Brain Tumor Association (ABTA) has been a leader in advancing the understanding and treatment of brain tumors. We do this through our engagement with patients and their families, our collaborations with allied groups and organizations, and through the funding of brain tumor research.


The ABTA was founded in 1973 – a period referred to by today’s brain tumor researchers as “the dark ages.”  Back then, there was no coordinated funding of brain tumor research, no medical specialty dedicated to brain tumor treatment and care, no national tracking of brain tumor diagnoses, and no reliable resource for patients and families seeking to better understand and cope with a brain tumor diagnosis.


The ABTA has been a leader in moving the field forward in all of these areas. We were the first and are now the only national organization committed to both raising funds for brain tumor research and providing information, resources and support to brain tumor patients and their families. Our goal is to improve, extend and, ultimately, save the lives of those impacted by a brain tumor diagnosis.


Unlike other diseases, where there is often a family history that serves as a warning and in some cases measures that one can take to mitigate risk, that is not the case with brain tumors.  For all the advances made over the past 40 years, we still don’t know who, we don’t know when, and, perhaps most frustrating of all, we don’t know why.


What we do know is that, for the past 40 years, the ABTA has been a leader in the pursuit of answers to these questions.  As the ABTA marks the 40th anniversary of its founding, we need your help to ensure that for as long as these questions remain, the 700,000 brain tumor patients and their families will know the American Brain Tumor Association is here for them, providing and pursing answers.  



Elizabeth M. Wilson
President & CEO